Sanofi (BIT:1SAN)

Market Cap	95.93B
Revenue (ttm)	45.74B
Net Income (ttm)	9.13B
Shares Out	n/a
EPS (ttm)	7.36
PE Ratio	10.51
Forward PE	9.68
Dividend	3.92 (4.86%)
Ex-Dividend Date	May 12, 2025

Volume	4,293
Average Volume	4,912
Open	80.98
Previous Close	80.72
Day's Range	80.66 - 81.35
52-Week Range	76.76 - 111.00
Beta	0.44
RSI	40.42
Earnings Date	Oct 24, 2025

About Sanofi

Sanofi engages in the research, development, manufacture, and marketing of therapeutic solutions. It provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; influenza, booster, meningitis, and travel and endemic vaccines, that includes hepati...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Borsa Italiana
• Ticker Symbol: 1SAN

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.